Characteristics of the study population
Blood cell parameters . | Subjects* . | |||
---|---|---|---|---|
African controls (n = 11) . | Non-VOC group (n = 15) . | VOC group (n = 17) . | HU group (n = 9) . | |
Leukocytes† | 4.40 ± 0.29 | 12.50 ± 0.551-155 | 13.47 ± 1.101-155 | 10.12 ± 0.671-155,1-154 |
PMNs† | 2.15 ± 0.24 | 6.13 ± 0.391-155 | 6.08 ± 0.511-155 | 5.05 ± 0.541-155 |
Monocytes† | 0.30 ± 0.01 | 1.07 ± 0.021-155 | 0.92 ± 0.011-155 | 0.88 ± 0.011-155 |
Platelets† | 266 ± 18 | 440 ± 291-155 | 444 ± 311-155 | 386 ± 291-155 |
Hb‡ | 124 ± 3 | 80 ± 21-155 | 75 ± 21-155 | 82 ± 41-155 |
HbF1-153 | — | 11.2 ± 1.4 | 8.3 ± 1.11-159 | 12.4 ± 1.9 |
Blood cell parameters . | Subjects* . | |||
---|---|---|---|---|
African controls (n = 11) . | Non-VOC group (n = 15) . | VOC group (n = 17) . | HU group (n = 9) . | |
Leukocytes† | 4.40 ± 0.29 | 12.50 ± 0.551-155 | 13.47 ± 1.101-155 | 10.12 ± 0.671-155,1-154 |
PMNs† | 2.15 ± 0.24 | 6.13 ± 0.391-155 | 6.08 ± 0.511-155 | 5.05 ± 0.541-155 |
Monocytes† | 0.30 ± 0.01 | 1.07 ± 0.021-155 | 0.92 ± 0.011-155 | 0.88 ± 0.011-155 |
Platelets† | 266 ± 18 | 440 ± 291-155 | 444 ± 311-155 | 386 ± 291-155 |
Hb‡ | 124 ± 3 | 80 ± 21-155 | 75 ± 21-155 | 82 ± 41-155 |
HbF1-153 | — | 11.2 ± 1.4 | 8.3 ± 1.11-159 | 12.4 ± 1.9 |
Subjects described in “Patients, materials, and methods.”
Means ± SEM blood cell counts, × 109/L.
Means ± SEM of Hb values, g/L.
Means ± SEM of HbF, %.
Significantly different from controls (P< .05).
Significantly different from the other patient groups (P < .05).
Significantly different from HU-treated patients (P < .05).